Определение эффективности лечения рака предстательной железы в ближайшие сроки

1. Ткачев С.И. Лучевая терапия рака предстательной железы. Клиническая онкоурология. Под ред. Б.П. Матвеева. М., Вердана; 2003. с. 525–46.

2. Michalski J.M. External beam radiation therapy. Prostate cancer: Principles and practice. Ed. by P.W. Kantoff, P.R. Carroll, A.V. D'Amico. Philadelphia, Baltimore, LWW; 2002. p. 317–35.

3. Partin A.W., Yoo J., Carter H. et al. The use of prostate specific antigen clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 1993;150:110–14.

4. Partin A.W., Kattan M.W., Subong E.N. et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: a multi-institutional update. JAMA 1997;18:1445–51.

5. Roach M., Pickett B., Rosenthal S.A. et al. Defining treatment margins for six field conformal irradiation of localized prostate carcinoma. Int J Radiat Oncol Biol Phys 1994;28:267–75.

6. WHO handbook for reporting results of cancer treatment. Geneva (Switzerland). World Health Organization Offset Publication _ 48. Geneva; 1979.

7. Therasse P., Arbuck S.G., Eisenhauer E.A. et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 2000;92(3):205–16.

8. Матвеев Б.П., Бухаркин Б.В., Матвеев В.Б. Рак предстательной железы. М.; 1999.